Oramed (ORMP) targets a new patient subset after FDA setback. Learn how promising trials may revive its protein oral delivery ...

Get insights on AbCellera’s high valuation, AI-driven R&D losses, stock-based compensation, and how Canadian funding impacts ...

Sanofi acquires Dynavax for $2.2B, gaining Heplisav-B and promising vaccine pipeline. Click here to read my analysis of SNY stock and the DVAX acquisition.

Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.

Can the S&P 500 hit 10,000 by 2026? Read more about historical rallies and investor optimism heading into the New Year.

Ramaco Resources, Inc. announces $100M buyback amid strong liquidity and cost control. Click for more on METC and met coal ...

Esquire Financial Holdings, Inc. is rated a Hold due to its expensive valuation and strong fundamentals. Learn more about ESQ stock here.

ZIM Integrated Shipping Services Ltd. has surged on M&A rumors despite weak Q3 results and lower dividends. Click for ZIM ...

US GDP grew by an annual rate of 4.3% in Q3, adjusted for inflation. Not adjusted for inflation, current-dollar GDP grew by ...

Everest Group, Ltd. stock remains attractively valued, trading near tangible book after a challenging Q3-2025 with reserve ...

With a 9.64% yield, ample spillover income, and $6.2B liquidity, ARCC is well-positioned for income investors seeking stability and capital appreciation in a lower-rate environment.

This further supports BKH’s 3.9% dividend yield, which is well-covered by a 66% payout ratio. BKH is a Dividend King with 54 ...